entity

PA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
30Hypotheses
3Analyses
1Outgoing
0Incoming
2Experiments
3Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

HNRNPA2B1 Protein

protein · 5015 words

NPAS3 Gene

gene · 4037 words

UCHL1 (PARK5) Pathway in Parkinson's Disease

mechanism · 3394 words

HPA Axis Dysfunction in Neurodegeneration

mechanism · 3381 words

AMPA Receptor Neurons

cell · 3374 words

Outgoing (1)

TargetRelationTypeStr
STING1activatesprotein0.72

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Enteric Nervous System Dysfunction as Self-Reinforcing Patho 7.000 neurodegeneration Gut-Brain Axis in Parkinson's Disease: M
Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propa 6.000 neurodegeneration Gut-Brain Axis in Parkinson's Disease: M
Closed-loop transcranial focused ultrasound with 40Hz gamma 1.000 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.948 Alzheimer's disease Circuit-level neural dynamics in neurode
Multi-Biomarker Composite Index Surpassing Amyloid PET for T 0.933 neurodegeneration What amyloid threshold level is required
Closed-loop transcranial focused ultrasound targeting EC-II 0.922 Alzheimer's disease Circuit-level neural dynamics in neurode
Palmitoylethanolamide-Based Endocannabinoid Therapy 0.919 - Blood-brain barrier tight junction disru
Closed-loop transcranial focused ultrasound to restore hippo 0.912 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.900 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t 0.896 Alzheimer's disease Circuit-level neural dynamics in neurode
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa 0.887 - Do β-amyloid plaques and neurofibrillary
Closed-loop tACS targeting EC-II PV interneurons to enhance 0.867 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic restoration of hippocampal gamma oscillations vi 0.863 Alzheimer's disease Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 0.861 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.858 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.857 Alzheimer's disease Circuit-level neural dynamics in neurode
Gamma entrainment therapy to restore hippocampal-cortical sy 0.851 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic viral vector delivery via tFUS-mediated blood-br 0.846 Alzheimer's disease Circuit-level neural dynamics in neurode
Optogenetic restoration of hippocampal gamma oscillations vi 0.845 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II parvalbumin interneurons to 0.831 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Real-time gamma-guided transcranial focused ultrasound targe 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.824 neurodegeneration What are the mechanisms by which gut mic
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna 0.820 Alzheimer's disease Circuit-level neural dynamics in neurode
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 0.820 neurodegeneration What is the therapeutic window between i
CSF1R-TREM2 Co-Agonism for Sustained Microglial Expansion 0.808 neurodegeneration TREM2 agonism vs antagonism in DAM micro
Microglial TREM2-SYK Pathway Enhancement 0.798 neurodegeneration Cell type vulnerability in Alzheimers Di
Closed-loop transcranial focused ultrasound targeting CA1 PV 0.797 Alzheimer's disease Circuit-level neural dynamics in neurode
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
Closed-loop transcranial alternating current stimulation to 0.785 Alzheimer's disease Circuit-level neural dynamics in neurode

Mentioning Analyses (3)

Scientific analyses that reference this entity

Do oligodendrocytes require DNA repair enhancement or inhibition for neuroprotec

neurodegeneration | 2026-04-11 | 0 hypotheses

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or c

neurodegeneration | 2026-04-11 | 0 hypotheses

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (3)

Multi-agent debates referencing this entity

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate revealed a critical gap: while excitatory neurons show mitochondrial

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate revealed conflicting therapeutic approaches - enhancing DNA repair ve

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

Related Research

Hypotheses and analyses mentioning PA in their description or question text

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to

Score: 0.922 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau prop

Palmitoylethanolamide-Based Endocannabinoid Therapy

Score: 0.919 · unknown disease · 2026-04-16

**Background and Rationale** Neuroinflammation represents a critical pathological hallmark across multiple neurodegener

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.912 · Alzheimer's disease · 2026-04-12

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholec

Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma

Score: 0.900 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and bloc

Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and r

Score: 0.896 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant

Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Partially Irreversible

Score: 0.887 · unknown disease · 2026-04-12

## Mechanistic Overview Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Partially Irreversible starts from the

Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibiti

Score: 0.867 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau

Optogenetic restoration of hippocampal gamma oscillations via selective PV inter

Score: 0.863 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activatio

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stab

Score: 0.861 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization starts

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.858 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct

Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and bl

Score: 0.857 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagat

Gamma entrainment therapy to restore hippocampal-cortical synchrony

Score: 0.851 · Alzheimer's disease · 2026-04-02

## Mechanistic Overview Gamma entrainment therapy to restore hippocampal-cortical synchrony starts from the claim that m

Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening

Score: 0.846 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic viral vector delivery via tFUS-mediated blood-brain barrier opening to restore hippo

Optogenetic restoration of hippocampal gamma oscillations via selective SST inte

Score: 0.845 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective SST interneuron activati

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhyth

Score: 0.831 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and bl